Autism Spectrum Disorder Trial, Recruiting NCT07258914 Sponsor: Hospital Center Guillaume Régnier Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT07258914
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Autism Spectrum Disorder (ASD), confirmed by a psychiatrist or specialist
  • People aged between 18 and 65 years old
  • People who are currently experiencing significant depression, as measured by a specific clinical score (MADRS score greater than 20)
  • People whose psychiatric medications have not changed in the month before joining the trial
  • People who are covered by or entitled to French social security
  • People who have been fully informed about the study and have signed a form agreeing to take part

Who may not be able to join:

  • People who have certain other psychiatric conditions at the time of joining, such as an active manic episode or schizophrenia
  • People who are pregnant at the time of joining
  • People who have medical reasons that make it unsafe to receive repetitive Transcranial Magnetic Stimulation (rTMS) or to have an MRI scan — this includes a history of epilepsy, or having certain medical devices or metal implants in the body (such as a pacemaker, defibrillator, neurological stimulator, vascular or cardiac prosthesis, intracranial clips, a fluid shunt in the brain, or metal fragments in the eyes), or having claustrophobia (fear of enclosed spaces)
  • People who are under a legal protection order (such as guardianship or curatorship), people who are currently detained, or people who are hospitalised involuntarily under a legal order

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hospital Center Guillaume Régnier
Registry
ClinicalTrials.gov
Start date
19 December 2024
Est. completion
19 February 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Difference in MADRS (Montgomery-Asberg Depression Rating Scale ) score before versus after treatment.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov